A new report by Data Bridge Market Research states that the global marijuana infused products market is currently valued at almost $30 billion, and is expected to see rapid growth in the coming years.
In the report Data Bridge Market Research predicts that the cannabis infused products market which was $29.68 billion in 2022, would rocket up to $150.51 billion by 2030, and is expected to undergo a compound annual growth rate (CAGR) of 22.5% during the forecast period 2023 to 2030.
“Cannabis is increasingly recognized as an effective treatment for many conditions, including nausea and vomiting brought by chemotherapy, restlessness, muscle tightness, and chronic discomfort”, states the report, pointing out some of the key drivers of market growth. “CBD and THC-infused edibles are becoming increasingly popular in all legal states. Furthermore, customers and investors are becoming more interested in infused beverages.”
The report notes that “The therapeutic properties of cannabis and the ongoing legalization of cannabis capsules will serve as opportunities for market expansion.”
Some of the major players operating in the cannabis infused products market, according to the report:
- Joy Organics (U.S.)
- CBD istillery (U.S.)
- Gaia Botanicals (U.S.)
- Harmony (U.S.)
- Floyd’s of Leadville (U.S.)
- Lazarus Naturals (U.S.)
- cbdMD (U.S.)
- Pure Hemp Botanicals (U.S.)
- ENDOCA(Netherlands)
- Green Roads (U.S.)
- Tilray (U.S.)
- Canopy Growth Corp. (Canada)
- GW Pharmaceuticals PLC (U.K.)
- Aurora Cannabis (Canada)
- Aphria Inc. (Canada)
- CV sciences Inc. (U.S.)
Data Bridge Market Research, founded in 2015, has over 500 analysts working in different industries, and they cater to more than 40% of the fortune 500 companies globally.
You can find more information on this report by clicking here.
More articles from The Marijuana Herald:
